Épisodes

  • Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement

    Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement
    Dec 10 2025

    Interview with Alfred E. Buxton, MD, and Marie-France Poulin, MD, authors of Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement. Hosted by Kristen K. Patton, MD.

    Related Content:

    • Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement
    Voir plus Voir moins
    19 min
  • From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more

    From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more
    Sep 16 2025
    Special edition of the JAMA Editor's Summary featuring the JAMA Network articles published at the 2025 European Society of Cardiology Congress. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, with JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS. Related Content: Remote Screening for Asymptomatic Atrial FibrillationLong-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial FibrillationSystolic Blood Pressure and Microaxial Flow Pump–Associated Survival in Infarct-Related Cardiogenic ShockHelicobacter pylori Screening After Acute Myocardial InfarctionPhysiology-Guided Complete Revascularization in Older Patients With Myocardial InfarctionFractional Flow Reserve–Guided Complete vs Culprit-Only Revascularization in Non–ST-Elevation Myocardial Infarction and Multivessel DiseaseTranscatheter or Surgical Treatment of Patients With Aortic Stenosis at Low to Intermediate RiskSemaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionBivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older AdultsHigh-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older AdultsRisk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza VaccineClonal Hematopoiesis and Risk of New-Onset Myocarditis and PericarditisParticipation of Women in Cardiovascular Trials From 2017 to 2023Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region
    Voir plus Voir moins
    38 min
  • Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

    Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
    Sep 10 2025

    Interview with Frederick L. Ruberg, MD, and Mathew S. Maurer, MD, authors of Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. Hosted by Sadiya Khan, MD.

    Related Content:

    • Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
    Voir plus Voir moins
    18 min
  • Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF

    Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF
    Aug 27 2025

    Interview with Margaret Infeld, MD, MS, author of Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction: Follow-Up of the myPACE Trial. Hosted by Robert Bonow, MD.

    Related Content:

    • Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction
    Voir plus Voir moins
    21 min
  • Preserving and Promoting Clinical Trial Representativeness

    Preserving and Promoting Clinical Trial Representativeness
    Jul 30 2025

    Interview with Roxana Mehran, MD, author of Preserving and Promoting Clinical Trial Representativeness: A Review of Existing Strategies and the Path Forward. Hosted by Robert Bonow, MD.

    Related Content:

    • Preserving and Promoting Clinical Trial Representativeness
    Voir plus Voir moins
    16 min
  • CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy

    CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy
    Jun 18 2025

    Interview with Michael McDermott, MBChB, author of CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy: A Nested Substudy of the SCOT-HEART 2 Randomized Clinical Trial, and Pamela S. Douglas, MD, author of The Last Mile in Prevention—Can Coronary CT Angiography Help? Hosted by Ann Marie Navar, MD, PhD.

    Related Content:

    • CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy
    • The Last Mile in Prevention—Can Coronary CT Angiography Help?
    Voir plus Voir moins
    19 min
  • Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation

    Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation
    Apr 30 2025

    Interview with Leonoor F. J. M. Wijdeveld, BSc and Sean J. Jurgens, MD, MSc, PhD, authors of Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation. Hosted by Sharlene Day, MD.

    Related Content:

    • Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation
    • Genetic Testing in Early-Onset Atrial Fibrillation
    Voir plus Voir moins
    15 min
  • Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation

    Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation
    Mar 26 2025

    Interview with Alexander C. Fanaroff, MD, MHS, author of Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation: Two Cluster Randomized Clinical Trials. Hosted by Ann Marie Navar, MD, PhD.

    Related Content:

    • Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation
    Voir plus Voir moins
    20 min